What is Biosynthetic Technologies?
Biosynthetic Technologies is at the forefront of manufacturing sustainable base oils through proprietary biobased synthetic compounds known as Estolides. These compounds are derived from organic fatty acids, offering a high-performance and environmentally conscious alternative for various industrial applications. The company's product portfolio serves critical sectors including industrial lubricants, personal care, and metalworking fluids. A key differentiator for Biosynthetic Technologies is the inherent compatibility of its Estolides with existing lubricant formulations, facilitating seamless integration for its clientele. This focus on sustainable innovation positions the company as a key player in the green chemistry movement, addressing the growing demand for eco-friendly industrial solutions.
How much funding has Biosynthetic Technologies raised?
Biosynthetic Technologies has raised a total of $52.2M across 4 funding rounds:
Unspecified
$14.7M
Unspecified
$9M
Private Equity
$12M
Debt
$16.5M
Unspecified (2012): $14.7M, investors not publicly disclosed
Unspecified (2013): $9M, investors not publicly disclosed
Private Equity (2014): $12M supported by Evonik
Debt (2016): $16.5M, investors not publicly disclosed
Key Investors in Biosynthetic Technologies
Evonik
Evonik is a global leader in specialty chemicals, focusing on areas like resource efficiency and advanced materials. Their investment in Biosynthetic Technologies highlights a strategic interest in sustainable chemical innovations and biobased solutions.
What's next for Biosynthetic Technologies?
The recent major strategic investment in Biosynthetic Technologies signals a pivotal growth phase, likely aimed at scaling production capabilities and expanding market reach. With a foundation built on sustainable and high-performance Estolides, the company is well-positioned to capitalize on the increasing global demand for environmentally responsible industrial materials. Future endeavors will likely focus on further research and development to enhance product lines and explore new applications, solidifying its leadership in the biobased lubricants and specialty chemicals market. Strategic partnerships and broader distribution channels are anticipated as the company leverages this latest capital infusion to accelerate its enterprise-level expansion.
See full Biosynthetic Technologies company page
